HIV-protease inhibitors.
Flexner
C
C
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004347:Drug Interactions; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D016333:HIV Protease / Q000737:chemistry; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015394:Molecular Structure; D017211:Treatment Failure
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D016333:HIV Protease